Crescendo Health Announces Official Launch
Crescendo Health has announced its official launch. Founded by the co-founder of Datavant (merged with Ciox in a $7 billion deal), and a product-management leader from Grand Rounds (merged with Doctor On Demand to form Included Health), Crescendo Health is a public benefit corporation that is seeking to improve access to traditionally siloed health data for both patients and clinical research sponsors. The company works with researchers from many types of healthcare organizations, including biopharma, medical device manufacturers, and contract research organizations, to provide the tools and support required to collect and integrate information from patients' routine clinical care.
Read more about the launch here.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
